NEMIC and KITOX Complete Summer-Long Program
Over the summer, NEMIC orchestrated the Global Build-Up Education Program in partnership with the Korea Institute of Toxicology (KITOX). This program was designed to help early-stage Korean life science companies plan a strategic entry into the US market and offered a virtual curriculum focused on essential aspects of startup development, pitch preparation, and fundraising and exit strategy, a curriculum that NEMIC is already very familiar with.
The program ran from July to September and featured 20+ participants per session, highlighting a high level of engagement and interest from the startups involved. Delivered via Zoom, the sessions covered 14 critical topics essential for success in the US life science landscape. These included US Life Science Investment Overview, Technology Transfer, Regulatory Strategy for Bio/Pharma Startups, Bio-Tech Ecosystem in the US, IP Strategy, Quality Assurance, Life Science M&A, Licensing, and Building a US Team and Governance Structure.
Through these topics, participants gained perspectives about key concepts for ensuring compliance and operational excellence when considering establishing a life science business in the US. In addition to scientific strategy content, the program offered insights into the capital-raising process in the US, with guidance on how to navigate investor roadshows, manage due diligence, and structure licensing and M&A deals. Case studies were incorporated to highlight potential pitfalls and strategies to lessen risks during the fundraising and deal-making processes. Participants were also given training on team-building strategy, an important factor in positioning their companies for long-term success in the US market.
NEMIC’s collaboration with KITOX was mutually beneficial, as KITOX sought to expand its network and gain knowledge from US-based experts. Through NEMIC’s network, participants had access to mentorship, educational resources, and the opportunity to connect with key opinion leaders in the life sciences and investment communities. This program not only supported the professional development of KITOX-affiliated startups but also fostered stronger ties between the US and Korean biotech ecosystems. By the end of the program, participants had a clearer understanding of the steps necessary to advance their companies and technologies in this US market. They left with insights into the investor mindset, regulatory pathways, and the operational requirements to scale their innovations globally.
The success of this program reiterates NEMIC’s ongoing commitment to supporting early-stage healthcare companies through tailored mentorship and education. The Global Build-Up Education Program marks another milestone in NEMIC’s mission to drive innovation and growth in the healthcare sector, creating new opportunities for global collaboration and impact.
